Fluoroquinolones and Risk for Methicillin-Resistant Staphylococcus aureus, Canada

Fluoroquinolones and Risk for Methicillin-Resistant Staphylococcus aureus, Canada

Receipt of fluoroquinolones was the predominant risk factor for Clostridium difficile–associated disease (CDAD) during an epidemic in Quebec, Canada. To determine the role of antimicrobial drugs in facilitating healthcare-associated methicillin-resistant Staphylococcus aureus (MRSA) colonization and...

Full description

Bibliographic Details
Main Authors: Louiselle LeBlanc, Jacques Pépin, Krystel Toulouse, Marie-France Ouellette, Marie-Andrée Coulombe, Marie-Pier Corriveau, Marie-Eve Alary
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2006-09-01
Series:Emerging Infectious Diseases
Subjects:
methicillin-resistant Staphylococcus aureus
methicillin-susceptible Staphylococcus aureus
fluoroquinolones
Canada
research
Online Access:https://wwwnc.cdc.gov/eid/article/12/9/06-0397_article

Internet

https://wwwnc.cdc.gov/eid/article/12/9/06-0397_article

Similar Items